Prostate News and Research

RSS

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

Improved delivery methods and better testing systems are needed to advance promising gene therapy strategies for treating prostate cancer, according to a series of review articles in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 Jul 2010

Lung cancer patients likely to suffer significant stigma due to disease's link to smoking: Study

Today, Lung Cancer Alliance highlighted a study, carried out by Ipsos MORI on behalf of The Global Lung Cancer Coalition. The study finds lung cancer patients are likely to suffer significant stigma due to the disease's link to smoking.

14 Jul 2010

Antigen Express granted patent for AE37 immunotherapeutic vaccine: Generex Biotechnology

Generex Biotechnology Corporation today announced that its wholly-owned subsidiary, Antigen Express, Inc., has been granted a United States patent on AE37, its lead immunotherapeutic vaccine. While Antigen Express has a strong intellectual property foundation on all Ii-Key technology, this is the first "composition of matter" patent to be issued relating to one of their development products.

14 Jul 2010

Study identifies protein that turns non-malignant tumor into metastatic neuroendocrine tumor

Some types of prostate tumors are more aggressive and more likely to metastasize than others. Nearly one-third of these aggressive tumors contain a small nest of especially dangerous cells known as neuroendocrine-type cells. More rarely, some aggressive prostate tumors are made up entirely of neuroendocrine-type cells. The presence of neuroendocrine-type cancer cells is associated with a poor prognosis, but spotting these rare cells can be like finding a needle in a haystack.

13 Jul 2010

SPET-085 is effective in blocking critical enzyme that leads to BPH: Study

A new study, published in the July issue of Advances in Therapy, revealed that a novel saw palmetto extract, SPET-085, is as effective as finasteride, the standard prescription drug therapy, in blocking the critical enzyme that leads to benign prostatic hyperplasia.

13 Jul 2010

Men with prostate cancer lose less bone mineral content as they age: Study

Men with prostate cancer lose significantly less bone mineral content (BMC) as they age than men who are free of the disease, according to research in the July issue of BJUI. The findings are important because loss of BMC can play a key role in the development of fragile bones, fractures and osteoporosis.

13 Jul 2010

GWAS suggests genetic variant with increased oncogene expression for cancer study

The study, published July 13th in Genome Research, showcases a new protocol for studying the activity of cancer-risk variants suggested by GWAS studies. The results also underscore the dramatic consequences of small genetic changes even in the vast stretches of DNA, known as "gene deserts," that do not code for proteins.

13 Jul 2010

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced that it has signed an agreement with Oncura, Inc. for the distribution of TheraSeed® palladium-103 brachytherapy seeds. Oncura is a unit of GE Healthcare. Under the terms of the agreement, Theragenics will be the exclusive palladium-103 seed supplier to Oncura, subject to certain pre-existing vendor agreements, for the treatment of prostate cancer in the U.S. and Canada.

12 Jul 2010

Oklahoma City ProCure Proton Therapy Center celebrates first-year anniversary

Past and present patients, families, friends, staff and physicians of ProCure Proton Therapy Center in Oklahoma City commemorated a year of achievements at a celebratory luncheon Thursday at the center in northwest Oklahoma City.

9 Jul 2010

Men with higher baseline PSA value more likely to die from prostate cancer, say researchers

Men who have a baseline PSA value of 10 or higher the first time they are tested are up to 11 times more likely to die from prostate cancer than are men with lower initial values, according to Duke University Medical Center researchers.

9 Jul 2010

Informed consent discussions lead to greater patient comprehension of surgical procedures

Surgical patients who participate in longer- to 30-minute- discussions prior to having an operation (known as the informed consent process) better understand the proposed operation, according to new research published in the June issue of the Journal of the American College of Surgeons. In addition, researchers found that asking the patient to "repeat back" their understanding of the procedure was effective in enhancing patient comprehension of informed consent issues. This is the largest study ever conducted on the surgical informed consent process.

8 Jul 2010

Omni Health Media announces launch of CancerConnect.com

Omni Health Media, one of the world's leading specialty publishers of health-related information, websites, applications, and educational programs for individuals with cancer and their caregivers announces the successful launch of CancerConnect.com during the Allen Media Conference in Sun Valley, ID. Cancer Connect is a new social network that will allow people with cancer and those who care for them to share information, inspiration, hope, and support.

8 Jul 2010

Nymox reports positive new results from pooled analysis of NX-1207 clinical trials for BPH

Nymox Pharmaceutical Corporation reported today positive new results from pooled analysis of completed clinical trials of NX-1207, the Company's investigational drug for BPH. The trial data shows that patients receiving NX-1207 recorded significant quantitative improvement in the important symptom of urgent need to urinate.

8 Jul 2010

Overall cancer mortality rates continue to decrease, new report shows

The continued drop in overall cancer mortality rates over the last 20 years has averted more than three-quarters of a million (767,000) cancer deaths according to a new report from the American Cancer Society. The American Cancer Society's annual Cancer Statistics article reports that the overall death rate from cancer in the United States in 2007 was 178.4 per 100,000, a relative decrease of 1.3 percent from 2006, when the rate was 180.7 per 100,000, continuing a trend that began in 1991 for men and 1992 for women.

8 Jul 2010

Patients are not presented with information about prostate cancer treatment options: Urologists

At the recent meeting of the American Urological Association in San Francisco, researchers presented studies regarding the decision making process men go through when considering proposed prostate cancer treatments. Dr. Vorstman, renowned Florida urologist, believes these studies would have more meaning if patients were presented with information about prostate cancer treatment options in a different fashion.

7 Jul 2010

Study finds additional targets for new therapies to treat advanced prostate cancer patients

In its early stages, prostate cancer requires androgens (hormones that promote the development and maintenance of male sex characteristics) for growth, and current first-line therapies target the receptor for these hormones to slow cancer's development and spread.

7 Jul 2010

VA addresses health concerns including possible HIV exposure and Veterans' general poor health

"The Democratic chairman of the House Veterans Affairs Committee lambasted the Obama administration over its handling of an incident at a St. Louis VA center in which more than 1,800 veterans were told they may have been exposed to HIV. ... The Department of Veterans Affairs last month sent a letter to 1,812 patients informing them that could have been exposed to HIV and other deadly viruses because of dental equipment that was insufficiently sterilized over a period of 13 months."

7 Jul 2010

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

A 64-year-old female patient with mediastinal metastasis recently became the first in Latin America to receive Elekta VMAT radiotherapy treatment enhanced with Monaco® planning software. Using the arc-based Elekta VMAT delivery method, Monaco displays how the radiation dose should be applied — its distribution and strength on the target. The result is a therapy that not only is rapid, but also fine-tuned to treat cancer and avoid healthy tissues.

From Elekta 3 Jul 2010

ZERO demands ACS apology on effectiveness of PSA test

With a new study showing the PSA test reduces the prostate cancer death rate by 44 percent, ZERO – The Project to End Prostate Cancer demands an apology for all at risk of the disease from the American Cancer Society, which has long discounted the importance of prostate cancer testing.

3 Jul 2010

Modified Citrus Pectin holds promise against prostate cancer

Researchers at Columbia University recently analyzed the positive effects of Modified Citrus Pectin (MCP) on human and mouse prostate cancer cell lines. The results, as reported by lead researcher Dr. Aaron Katz in the most recent publication of Integrative Cancer Therapies, show that MCP inhibits cell proliferation and induces apoptosis (programmed cell death) in both androgen-dependent and androgen-independent cancer cells in a time and dose-dependent manner.

2 Jul 2010

Prostate News and Research

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

Lung cancer patients likely to suffer significant stigma due to disease's link to smoking: Study

Antigen Express granted patent for AE37 immunotherapeutic vaccine: Generex Biotechnology

Study identifies protein that turns non-malignant tumor into metastatic neuroendocrine tumor

SPET-085 is effective in blocking critical enzyme that leads to BPH: Study

Men with prostate cancer lose less bone mineral content as they age: Study

GWAS suggests genetic variant with increased oncogene expression for cancer study

Theragenics signs supply agreement with Oncura for TheraSeed palladium-103 brachytherapy seeds

Oklahoma City ProCure Proton Therapy Center celebrates first-year anniversary

Men with higher baseline PSA value more likely to die from prostate cancer, say researchers

Informed consent discussions lead to greater patient comprehension of surgical procedures

Omni Health Media announces launch of CancerConnect.com

Nymox reports positive new results from pooled analysis of NX-1207 clinical trials for BPH

Overall cancer mortality rates continue to decrease, new report shows

Patients are not presented with information about prostate cancer treatment options: Urologists

Study finds additional targets for new therapies to treat advanced prostate cancer patients

VA addresses health concerns including possible HIV exposure and Veterans' general poor health

64-year-old female Latin American receives Elekta VMAT radiotherapy enhanced with Monaco planning software

ZERO demands ACS apology on effectiveness of PSA test

Modified Citrus Pectin holds promise against prostate cancer

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News